 | |||||
| cannabidiol for epilepsy | |||||
| NEWS | |||||
| Pharma Stock Drops After Raymond James Rating ... since its second quarter trading publicly, growth in the company's cannabidiol (CBD) -based epilepsy treatment Epidiolex is beginning to taper off.
| |||||
| Global Cannabidiol Supplements Market to Witness Heightened Growth During the Period 2019 ... Cannabidiol are widely used in the treatment of neuropsychiatric disorders such as epilepsy, schizophrenia, etc. Cannabinoids are also used in ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
